iLCT studies recruiting now
We fund and support clinical trials which seek to slow, stop or reverse Parkinson’s. We have clinical trials within the International Linked Clinical Trials programme that are actively seeking people to take part now.Read more here
Find other studies recruiting
New treatments for Parkinson’s will only become available after they have been tested in those volunteers affected by the disease.Find out more
The Clinical Trials Charter
The Clinical Trials Charter has been developed by people with Parkinson’s and clinicians.Find out more
Why take part in clinical research?
Participation in clinical trials requires a certain amount of selfless commitment but it can also be a rewarding experience allowing those who dedicate their time and energy to be a part of something much larger; something that has the potential to make a life-changing difference in the lives of many.
For some, it is the possibility that if a study is investigating a drug, participants might benefit from the treatment before it is available to many. Others sign up out of altruism, wanting to make a difference to future generations; and some join for curiosity to learn more about their Parkinson’s – essential if we are to develop personalised medicine solutions in the future. Another key factor is that clinical trial participants will see the research study team frequently (whether online or in person) in addition to their usual Parkinson’s appointments. This means that any changes in a participant’s Parkinson’s can be discussed, and if possible, addressed.
There is emerging evidence that the research-active have better overall health outcomes, for example, a 2020 publication, by researchers at Cumbria Partnership NHS Foundation Trust, found that patients admitted to more research-active hospitals have more confidence in staff and are better informed about their condition and medication.
With special thanks to Soania Mathur, whose blog was used in some of the content of this page.